(Photo via Twitter)
Bel Air-based medical device company Graftworx received $500,000 from the Maryland Venture Fund, the state announced.
With the new funding, the company announced the hiring of Lilip Lau, who invented a coronary stent while at Guidant. Graftworx is developing a stent to treat peripheral artery disease (PAD).
The money will also be used to complete pre-clinical trials, officials said.
When treating PAD, surgeons implant stents to bypass areas of the artery where blood flow is blocked. But there remains a high-risk that the stent itself will become blocked, which can lead to other complications, and, in some cases, amputations.
Graftworx is developing a stent with sensors that can connect to smartphones, and alert surgeons when there might be blockage.
“We are proud to make this investment in GraftWorx and look forward to their growth and success here in Maryland,” DBED Secretary Mike Gill said. “Small, innovative companies like GraftWorx are critical to Maryland’s economy.”-30-
UMB grants licensing option for anticancer drug that uses Anthrax
AgeneBio receives $3.4M for development of Alzheimer’s treatment
Frederick’s Veralox Therapeutics raises $5.4M seed round
Why two eminent Baltimore higher-ed institutions collaborated to create this unique dual degree program
Sysmex Inostics moves into bigger space near JHU medical campus
Frederick-based RoosterBio raises $15M Series B
Maryland VC totals ‘rebound’ with $226M raised in Q2
What Asymmetrik is doing to help lead healthcare’s digital transformation
Sign-up for daily news updates from Technical.ly Baltimore